US Drug Recall Register

FDA Drug Recalls

220 recalls · Class I, newest first

Class I · High risk Ongoing

Delsam Pharma's ARTIFICIAL TEARS

Reason Non-Sterility: FDA analysis found unopened products to have bacterial contamination.

Global Pharma Healthcare Private Limited D-0921-2023
Class I · High risk Ongoing

Artificial Tears

Reason Non-Sterility: FDA analysis found unopened products to have bacterial contamination.

Global Pharma Healthcare Private Limited NDC 79503-0101-15 D-0919-2023
Class I · High risk Ongoing

Adam's Polishes ALCOHOL BASED HAND SANITIZER

Reason Chemical Contamination: FDA analysis found 1 lot of Adam's Polishes ALCOHOL BASED HAND SANITIZER isopropyl alcohol 75% v/v to contain methanol.

Adam's Polishes LLC NDC 74943-125-04 D-0066-2023
Class I · High risk Ongoing

Lidocaine Hydrochloride

Reason Superpotent Drug

Teligent Pharma, Inc. NDC 63739-997-64 D-0295-2022
Class I · High risk Ongoing

ALPHA MALE+ Male Enhancer

Reason Marketed Without an Approved NDA/ANDA: FDA analysis determined the presence of tadalafil

Alpha-Tek LLC D-0001-2022
Class I · High risk Ongoing

Vy&Tea

Reason Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine.

Qikmoov LLC D-0749-2021
Class I · High risk Ongoing

Limar Hand Sanitizer

Reason Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.

Ardil Comercial S.R.L. D-0691-2021
Class I · High risk Ongoing

MEDICALLY MINDED Hand Sanitizer Gel

Reason Chemical Contamination: FDA analysis found 1 lot of MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA (ethyl alcohol 70%) to be below the label claim for ethanol content and to contain methanol.

Global Sanitizers LLC D-0781-2021
Class I · High risk Ongoing

MEDICALLY MINDED Hand Sanitizer Gel

Reason Chemical Contamination: FDA analysis found 1 lot of MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA (ethyl alcohol 70%) to be below the label claim for ethanol content and to contain methanol.

Global Sanitizers LLC D-0780-2021
Class I · High risk Ongoing

Ginseng Power 5000 capsule

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil

NSNY Distributor Inc D-0642-2021
Class I · High risk Ongoing

Premium OrgaZEN 7000 capsule

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil

NSNY Distributor Inc D-0641-2021
Class I · High risk Ongoing

69MODE Blue 69 capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making it an unapproved drug for which the safety and efficacy have not been established and therefore subject to recall.

Nuri Trading LLC D-0688-2021
Class I · High risk Ongoing

Thumbs Up 7 White 11K capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil sildenafil, and vardenafil, FDA approved drugs making them an unapproved drug for which the safety and efficacy have not been established and therefore subject to recall.

Nuri Trading LLC D-0687-2021
Class I · High risk Ongoing

Thumbs Up 7 Black 25K capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil, an FDA approved drug making this an unapproved drug for which the safety and efficacy has not been established and therefore subject to recall.

Nuri Trading LLC D-0686-2021
Class I · High risk Ongoing

Shogun-X 7000 capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Nuri Trading LLC D-0685-2021
Class I · High risk Ongoing

Enoxaparin Sodium Injection

Reason Labeling; Label Mixup; syringe barrels may contain markings for 100 mg/mL (corresponding to 100 mg/mL strength) instead of 150 mg/mL (corresponding to 120 mg/0.8mL strength)

Apotex Corp. NDC 60505-0796-4 D-0262-2021